Niki BioSolutions, Inc.

US$1.58As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NIKIHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (44.08%)
Div yield —
ROE (17.05%)
Biotechnology
Beta (5Y) (0.80)
PE TTM —
TSR TTM 9.72%
Mkt cap US$4.643M
ROIC (10.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.53
(3.27%)
(77.22%)
Hold 5|5|5|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
8.30%
0.77%
(3.62%)
1.00%
Revenue$M
0.221
0.221
0.230
0.230
10.55%
4.38%
8.17%
6.80%
Peers (US$4.643M)
Cap (US$)
PE
4.741M
—
4.439M
—
Capital
TTM
5Y
10Y
Leveragex
0.889
0.148
0.105
EBIT/Intx
0.972
0.577
0.370
Own earn%
(57.18)
(32.37)
(32.79)
Sh yield%
29.63
65.82
64.94
Owners
Insiders/Inst%
8.83
86.57
Short interest%
5.34
SBC / revenue%
0.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
14–20
$1 testx
0.0
Incr. ROIC%
66